Replies to post #14814 on Hemispherx BioPharma (HEB)

[JohnnyD3]

No problem. Here is the overview of todays presentation (the 1 hour video will be online in a couple of days):

Post-Infectious-Myalgic Encephalopathy/Chronic Fatigue Syndrome

Overall Hypothesis: PI-ME/CFS is triggered by a viral illness that results in immune mediated brain dysfunction

Phase I: To conduct a cross sectional study for deep phenotyping of PI-ME/CFS to define its pathophysiology

Phase II: To validate select biomarkers from phase I in a longitudinal study and establish objective end points for an intervention study

Phase III To conduct an early phase intervention study with an immunomodulatory agent that targets biomarkers validated in Phase II
====

NIH already knows they are going to use an immunomodulatory agent. I wonderrrrrrrr what it could be???